News
- Global regulatory workshop on COVID-19 real-world evidence and observational studies
- HHS, DOD Partner With Sanofi and GSK on Commercial-Scale Manufacturing Demonstration Project to Produce Millions of COVID-19 Investigational Vaccine Doses
- Johns Hopkins receives $35M in federal funding for COVID-19 blood plasma trials
- DND awards $2 million to two companies developing COVID-19 solutions and products
- FDA Warns Companies Illegally Selling Hangover Remedies
- PAHO, COICA and other indigenous groups seek to reduce the impact of COVID-19 on Amazonian peoples
- HHS Issues New Report Highlighting Dramatic Trends in Medicare Beneficiary Telehealth Utilization amid COVID-19
- Hepatitis prevention and treatment services must continue during the COVID-19 pandemic to ensure progress towards elimination, says PAHO
- WHO urges Turkmenistan to activate critical measures to prepare for COVID-19 outbreak
- Bringing hepatitis C testing and treatment to underserved communities in Madrid, Spain
- Safe practices during Eid al-Adha in the context of COVID-19
- Ethiopia vaccinates nearly 15 million children against measles despite COVID-19 challenges
- Testing, treatment and comprehensive prevention – how a nurse-led program is dealing with hepatitis in prisons in Luxembourg
- HHS Reserves and Rapidly Expands Manufacturing Capacity for COVID-19 Vaccines at Texas Center for Innovation in Advanced Development and Manufacturing
- Phase 3 clinical trial of investigational vaccine for COVID-19 begins
- First antibody-drug conjugate for multiple myeloma patients with limited treatment options
- Vaginal ring to reduce the risk of HIV infection for women in non-EU countries with high disease burden
- EMA starts review of dexamethasone for treating adults with COVID-19 requiring respiratory support
- Authorised uses of cancer medicine Yondelis unchanged following review of new data
- Panexcell Clinical Laboratories: suspension of medicines over flawed studies
- FDA Approves First Cell-Based Gene Therapy For Adult Patients with Relapsed or Refractory MCL
- The ADA at 30: the Importance of Law and Health Policy in Expanding Equity
- WHO statement on heated tobacco products and the US FDA decision regarding IQOS
- World Hepatitis Day: fast-tracking the elimination of hepatitis B among mothers and children
- New country support package launched to accelerate salt reduction in the WHO European Region
Clinical Research News
Aankomende klinische onderzoeken
-
Artvin Coruh UniversityNog niet aan het wervenZiekte van Charcot Marie Tooth (CMT)Turkije (Türkiye)
-
University of Management and Technology LahoreNog niet aan het wervenArtrose van de kniePakistan
-
Regeneron PharmaceuticalsWervingGeavanceerde solide tumorenVerenigde Staten
-
Kirsehir Ahi Evran UniversitesiNog niet aan het wervenKindermishandeling | Verpleegkundige opleiding | Verwaarlozing van kinderen | Seksueel misbruik van kinderen
-
Lokman Hekim UniversityNog niet aan het wervenVerpleegkundige opleidingTurkije (Türkiye)
-
Imagion Biosystems, Inc.WervingHER2-positieve borstkankerVerenigde Staten
-
Ankara City Hospital BilkentWervingAngst voor de bevalling | Keizersnede | LABOR PAİNTurkije (Türkiye)
-
Örebro University, SwedenWerving
-
Oorja Bio, Inc.Werving
-
Cairo UniversityNog niet aan het wervenCervicale radiculopathie bij zenuwwortel C6Egypte
-
Indiana UniversityWervingZwangerschapspreventie | Mannelijke anticonceptie | Anticonceptiemiddel | Prevention of Semen Exposure During IntercourseVerenigde Staten
-
Tianjin Medical University Cancer Institute and...Nog niet aan het wervenMantelcellymfoom (MCL) | Recidiverend/Refractair Mantelcellymfoom (MCL)China